Prepares exuding wounds for healing

  • Description
  • Benefits
  • Indications
  • In Practice
  • FAQs
  • Evidence
  Download product information

Absorbent calcium alginate and hydrocolloid dressing

Preparing exuding wounds for healing

  • Absorbs exudate
  • Facilitates desloughing and healing
  • Can be removed in one piece
  • Haemostatic properties

Absorption capacity

UrgoSorb absorbs 26.6 g/100 cm2, whereas the reference hydrofibre only absorbs 18.5 g/100 cm2 illustrating the superior draining capacity of UrgoSorb.

URGOSORBComposition

Urgosorb is an absorbent dressing combining calcium alginate fibres with hydrocolloid particles.

Mode of action

When in contact with exudate, sodium-calcium ion exchange takes place between the wound and the dressing, UrgoSorb gels and maintains the moist environment favourable for the healing process. UrgoSorb absorbs the exudate, softens and drains any necrotic debris.

Through platelet activation, Urgosorb dressing promotes primary haemostasis of acute and chronic bleeding wounds.


This website is an international website. Some products or sizes can therefore be unavailable in some countries. For more information, please contact us.

Benefits for the wound

  • Exudate management (vertical absorption protecting peri-wound skin from maceration)
  • Moist wound healing
  • Haemostatic properties

benefits-for-professionnalBenefits for health professionals

  • Debridement capability
  • Exudate absorption
  • One piece removal
  • Moist wound healing
  • Haemostatic properties
  • Easy to apply and to remove
  • Atraumatic dressing changes
  • May be used under compression
  • Clinically proven

benefits-for-patientBenefits for patients

  • Atraumatic dressing changes
  • Comfortable and well tolerated

UrgoSorb is indicated for exuding and bleeding wounds, during the sloughy and granulation stage.

Contraindications

Urgosorb is contraindicated for the endonasal cavity in rhinoplastic surgery, third degree burns, dry necrotic tissue or eschar and the control of heavy bleeding. Do not use as an implantable surgical pad

Instructions for use

  • Clean the wound as per local protocol and rinse with saline solution. Dry the surrounding skin carefully.
  • If an antiseptic is first used, rinse the wound thoroughly with saline solution before applying Urgosorb.
  • Choose the appropriate size of Urgosorb which leaves at least 1 or 2 cm of the dressing overlapping the healthy skin around the wound.
  • Apply Urgosorb directly onto the wound.
  • For deep or tunnel wounds (anfractuous pressure ulcers, pilonidal sinus), apply Urgosorb rope loosely without any excessive pressure.
  • Cover Urgosorb with a secondary dressing.
  • Secure the dressing in place with a suitable bandage, adhesive tape, or apply compression bandage if prescribed.
  • Urgosorb should be changed when it is saturated, particularly when the exudate has soaked through to the secondary dressing. The renewal frequency depends on the level of exudate:
    • daily in case of highly exuding wounds either covered with fibrinonecrotic debris or infected;
    • every 2 days in case of a clean and moderately exuding wound, depending on the clinical condition of the wound.
  • In case of a leg ulcer, Urgosorb can be moistened with saline solution in order to ease the removal.

Precautions for use

  • If clinical signs of local infection are noted, the treatment may be continued under medical supervision. However, the use of Urgosorb Ag/Silver is preferable.
  • Urgosorb should be stored away from light, heat and moisture.
  • Discard any unused parts of the dressing.
  • Check that the sterility protector is intact before use.
  • Sterile individual packaging, for single use: re-using a single use dressing may lead to risks of infection.
  • Do not re-sterilise the dressing.

urgosorb_10x20Sizes available

Pad:

  • 5 cm x 5 cm
  • 5 cm x 10 cm
  • 10 cm x 10 cm
  • 10 cm x 12 cm
  • 10 cm x 20 cm

Rope:

  • 5 cm x 30 cm

This website is an international website. Some products or sizes can therefore be unavailable in some countries. For more information, please contact us.

Product

What is UrgoSorb?

UrgoSorb is an absorbent dressing combining calcium aginate with hydrocolloid particles.

How does UrgoSorb work?

When in contact with exudate, sodium-calcium ion exchange takes place between the wound and the dressing. UrgoSorb gels and maintains the moist environment favourable for the healing process. UrgoSorb absorbs exudate, softens and drains any necrotic debris. Through platelet activation, the Urgosorb dressing promotes primary haemostasis of acute and chronic bleeding wounds.

What is the absorption capacity of UrgoSorb compared to other dressings?

UrgoSorb absorbs 26.6 g/10x10cm dressing, more than hydrofibre dressings (Aquacel 18.5g/dressing).

What is the difference between UrgoSorb and hydrofibre dressings?

Hydrofibre dressings are composed of hydrocolloid fibres which gel and maintain a moist environment and absorb exudate.
Dressings which contain calcium alginate also have haemostatic and desloughing properties and can be removed in one piece.

Indications

When should I use UrgoSorb?

UrgoSorb is indicated for exuding and bleeding wounds, during the sloughy and granulation stage.

Can I use UrgoSorb during the granulation stage?

Yes. However, if the wound is chronic, UrgoStart is the perfect treatment to accelerate wound healing.

Can I use UrgoSorb with a gel?

Yes, it can be combined with a hydrogel.

What are the contraindications of UrgoSorb?

Urgosorb is contraindicated for packing the endonasal cavity in rhino-plastic surgery, third degree burns, dry necrotic tissue or eschar, surgical implants or to control heavy bleeding.

Use

Can I cut UrgoSorb?

Yes. Cutting Urgosorb does not affect its action or absorbency.

How can I secure UrgoSorb?

Secure the dressing in place with a suitable bandage, adhesive tape, or apply compression bandage when prescribed.

Can I use UrgoSorb under compression?

Yes. Compression bandages do not affect the action or benefits of the dressing.

When should I change UrgoSorb?

Urgosorb should be changed when it is saturated, particularly if the exudate is seeping through to the secondary dressing. The renewal frequency depends on the level of exudate:

  • daily in case of highly exuding wounds which are either covered with fibrinonecrotic debris or infected;
  • every 2 days in case of a clean and moderately exuding wound, depending on the clinical condition of the wound.
JWC_Alginate-Dressing BJN-1415-Urgosorb-dressing_web  

Alginate dressings – Do they influence wound healing?

Urgosorb™ dressing: management of acute and chronic wounds

 
Download Download  

Sequential treatment with Calcium Alginate Dressings and Hydrocolloid Dressings Accelerates Pressure Ulcer Healing in Older Subjects: A Multicenter Randomized Trial of Sequential versus Nonsequential Treatment with Hydrocolloid Dressings Alone

Belmin J. et al, JAGS 50:269-274, 2002

  • Objectives: To compare the efficacy of a sequential strategy combining calcium alginate and hydrocolloid dressings of grade III or IV pressure ulcers (PUs) and the efficacy of nonsequential strategy with hydrocolloids alone.
  • Design: An open, randomized, multicenter parallel-group trial.
    • Setting: Twenty geriatrics hospital wards.
    • Participants: One hundred ten older patients with grade III or IV PUs.
    • Intervention: The control strategy consisted of applying hydrocolloid dressings (DuodermE) for 8 weeks; the sequential strategy consisted of applying combined calcium alginate dressings (UrgoSorb) for the first 4 weeks and hydrocolloid dressings (Algoplaque) for the next 4 weeks.
    • Measurements: PU surface areas were measured weekly by ulcer tracing. The endpoints were the mean absolute surface area reduction (SAR) during the 8-week study period and the number of patients achieving a 40% or more SAR (SAR40).
  • Results: Fifty-seven and 53 patients were randomly allocated to sequential and control strategies respectively. Baseline patient characteristics and PU ulcer features at inclusion were similar in the two groups. Mean ± standard deviation SAR was significantly larger in the sequential treatment group (5.4 ± 5.7 cm2 and 7.6 ± 7.1 cm2 at 4 and 8 weeks) than in the control group (1.6 ± 4.9 cm2 and 3.1 ± 7.2 cm2, P < .001). In the sequential treatment group, 68.4% of the patients reached SAR40 at 4 weeks and 75.4% at 8 weeks, proportions significantly larger than in the control group (22.6% and 58.5%, respectively, P < .001). Dressing tolerance was good in both strategies.
  • Conclusions: In grade III or IV PUs, treatment using first calcium alginate dressings and then hydrocolloid dressings and then hydrocolloid dressings promotes faster healing than treatment with hydrocolloid dressings alone.

 

Last update : November 23, 2017